Loading clinical trials...
Loading clinical trials...
A Double-Blind, Placebo-Controlled Study of Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors
Conditions
Interventions
Dronabinol
Placebo
Locations
1
United States
University of Chicago
Chicago, Illinois, United States
Start Date
October 1, 2018
Primary Completion Date
July 20, 2021
Completion Date
November 1, 2021
Last Updated
June 2, 2022
NCT07224126
NCT05003401
NCT04241120
NCT00354770
NCT01875445
NCT04731389
Lead Sponsor
University of Chicago
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions